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Abstract
Background: The act of detecting bodily changes is a pre-requisite for subsequent responses to symptoms, such as
seeking medical help. This is the first study to explore associations between self-reported body vigilance and help-
seeking in a community sample currently experiencing cancer ‘alarm’ symptoms.
Methods: Using a cross-sectional study design, a ‘health survey’ was mailed through primary care practices to 4913
UK adults (age ≥50 years, no cancer diagnosis), asking about symptom experiences and medical help-seeking over
the previous three months. Body vigilance, cancer worry and current illness were assessed with a small number of
self-report items derived from existing measures.
Results: The response rate was 42% (N = 2042). Almost half the respondents (936/2042; 46%) experienced at least
one cancer alarm symptom. Results from logistic regression analysis revealed that paying more attention to bodily
changes was significantly associated with help-seeking for cancer symptoms (OR = 1.44; 1.06-1.97), after controlling
for socio-demographics, current illness and cancer worry. Being more sensitive to bodily changes was not
significantly associated with help-seeking.
Conclusions: Respondents who paid attention to their bodily changes were more likely to seek help for their
symptoms. Although the use of a cross-sectional study design and the limited assessment of key variables preclude
any firm conclusions, encouraging people to be body vigilant may contribute towards earlier cancer diagnosis.
More needs to be understood about the impact this might have on cancer-related anxiety.
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Background
The World Health Organisation highlights two major
components of early cancer detection: education to pro-
mote recognition of warning signs; and screening [1]. As
relatively few cancers are detected through screening [2],
understanding how people recognise and interpret bodily
changes is central to improving cancer outcomes [3, 4].
The Model of Pathways to Treatment (MPT) defines
the patient interval as time from first experiencing a
bodily change to first consultation with a healthcare
professional, and is divided into appraisal and help-
seeking components [3].
Although detecting relevant bodily changes is the first
step towards recognising cancer symptoms, research has
mainly focused on the help-seeking interval (time from
perceiving a reason to contact a healthcare professional to
first consultation) [3, 5–7]. However, delay associated with
symptom appraisal (time from detecting bodily changes to
perceiving a reason to discuss symptoms with healthcare
professional) is considered a key factor influencing time to
diagnosis [8], accounting for at least 60% of patients’ total
delay [9, 10]. Qualitative evidence using MPT as a frame-
work suggests that key factors prolonging the appraisal
interval include patient factors (e.g. misinterpretation, at-
tributing symptoms to benign causes, comorbidities) and
disease factors (e.g. disease site) [11–13].
Symptom appraisal models are helpful in further unpack-
ing patient response processes in the appraisal interval
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stage [14]. For example, attention appears to be critically
important in the detection phase because self-focused at-
tention is needed to detect bodily changes [14, 15]. To date,
body vigilance, defined as conscious attention focused on
bodily sensations [16], has mainly been researched in terms
of its association with anxiety-related constructs, such as
anxiety sensitivity [17] and panic disorder [16]. However, it
may also be an important construct to study in the context
of cancer symptom identification and presentation.
Studies in non-clinical samples and those with anxiety
disorders have suggested that heightened body vigilance
can enhance medical help-seeking [18]. Yet to our know-
ledge, no studies have explored associations between body
vigilance and help-seeking among those experiencing pos-
sible cancer symptoms. One study among asymptomatic
Dutch adults found women and the more educated were
more likely to anticipate paying attention to cancer symp-
toms [19]. However, attention to cancer symptoms was
not directly assessed in this research and there was no as-
sessment of help-seeking.
The Body Vigilance Scale [16], which is a widely used
measure of body vigilance and has been validated in non-
clinical samples, includes two items that may be relevant
in the context of earlier diagnosis. One of these items is
related to whether individuals pay close attention to their
bodily sensations, whereas the other is related to whether
individuals are sensitive to bodily sensations. The aim of
the current study was to examine the association be-
tween these two elements of self-reported body vigi-
lance and help-seeking among adults reporting cancer
‘alarm’ symptoms.
Methods
Study design and recruitment of participants
A detailed description of the study methods has been given
previously [20, 21]. Briefly, in October 2013, 4931 question-
naires were sent to patients registered at four general prac-
tices across London, the South East and the North West of
England. Participants were men and women aged ≥50 years,
with no current cancer diagnosis. Non-responders received
a reminder letter and questionnaire pack after 2 weeks.
The questionnaire
Symptom experience and help seeking
The questionnaire was presented as a general health sur-
vey to avoid alerting people to the cancer context. Re-
spondents were asked whether they had experienced one
or more of 14 cancer ‘alarm’ symptom in the past three
months (Table 1). Ten were taken from the Cancer
Awareness Measure [22], with an additional four from
the Be Clear on Cancer Campaigns [23]. For each symp-
tom reported in the last three months, respondents were
asked whether they had sought help from a General
Practitioner (GP) (‘yes’ or ‘no’).
Body vigilance
Two items assessing body vigilance ‘I am very sensitive
to changes in my body’ (BV-sensitivity) and ‘I pay close
attention to changes in my body’ (BV-attention) were se-
lected and adapted from the Body Vigilance Scale [16].
The items were considered independently because of
their semantic and conceptual differences; one assessed
perceived sensitivity to bodily changes (a more reactive,
passive response) and the other assessed degree of atten-
tional focus (suggestive of a more pre-emptive form of
vigilance). Responses were on a five-point Likert Scale
from ‘strongly disagree’ to ‘strongly agree’.
Cancer worry
A measure of cancer worry was included based on evi-
dence that it is associated with body vigilance, and may be
a potential confounder in the relationship between body
vigilance and help-seeking. Worry about cancer was mea-
sured with a question taken from Berrenberg’s cancer atti-
tude inventory [24], ‘On a day-to-day basis, how much do
you worry about cancer’. Responses were on a five-point
Likert scale (from ‘not at all’ to ‘a lot’). The question was
embedded among items on worry about two non-cancer
diseases to mask the cancer context.
Socio-demographic characteristics
Respondents were asked for their age (categorised for
analysis as 50–59; 60–79; 80+), ethnicity (white versus
non-white ethnic background), highest level of education
(degree or higher versus below degree), marital status
(married/cohabiting versus not married/cohabiting) and
employment status (working versus not working). They
were also asked whether they had a current diagnosis of
cancer (yes/no) or if they had any current illness that in-
terfered with their daily life (yes/no).
Table 1 Cancer ‘alarm’ symptoms
Persistent cough or hoarseness
Unexplained lump
Unexplained weight loss
Change in the appearance of a mole or a new mole
Persistent change in bowel habits
Persistent change in bladder habits
Abdominal bloating (i.e. bloating of the tummy or belly)
Unexplained pain
Difficulty swallowing
Blood in urine
Rectal bleeding (i.e. bleeding from the back passage
or blood in the bowel motions)
Other unexplained bleeding
Any breast changes
A sore that does not heal
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Statistical analysis
Data were analysed using SPSS 22.0. Spearman’s correla-
tions were calculated for the two body vigilance items.
As body vigilance is considered an anxiety-related con-
struct [16], correlations between each of the body vigi-
lance items and cancer worry were also examined.
Cancer worry was categorised into Low (not at all, a lit-
tle or moderately) and High (quite a bit, a lot). Both body
vigilance items were dichotomised as Endorsed (‘slightly
or strongly agree’) or Not Endorsed (‘neither agree nor dis-
agree’, ‘slightly or strongly disagree’). Categorisation of vari-
ables was based on our previous research to allow results
to be comparable [25].
Univariable analysis, namely logistic regression, was
initially used to explore associations between socio-
demographic, psychological variables and help-seeking.
Variables that were associated with help-seeking in
univariable analyses at p < 0.25 [26] were entered into
the multivariable logistic regression models. Two mul-
tivariable models were used to explore whether the
two elements of body vigilance were independently as-
sociated with help-seeking.
Results
Response
A total of 2042 people returned completed questionnaires
(response rate = 42%). Respondents were 54% female with
an average age of 65 (range: 50–100 years). Most (94%)
were white and 68% were married or co-habiting, 37% were
educated to university level, and 41% were employed. These
demographics are comparable to the profile of over 50 year
olds in England [25], although non-white ethnic groups
were under-represented. Symptomatic respondents were
more likely to be female [X2 (1) = 16.81, p < .01)], single [X2
(1) = 17.93, p < .01)], have a current illness [X2 (1) = 66.27,
p < .01)], report high cancer worry ([X2 (1) = 20.66, p < .01)]
and be sensitive to bodily changes [X2 (1) = 5.43, p < .05)],
compared to asymptomatic respondents (Table 2).
Non-responder analysis showed that the probability of
not responding was greater for men (39.4%) than women
(44.3%) [X2 (1) = 11.70, p < .01)], and for 50–59 year olds
(34.2%) than 60–69 year olds (49.4%) or those 70 and over
(45.3%) [X2 (2) = 92.48, p < .001].
Almost half the sample (46%; 936/2042) reported ex-
periencing at least one cancer alarm symptom over the
previous three months. Of these, 18 were excluded as
they reported a diagnosis of cancer and 1 was excluded be-
cause they had missing data for the ‘cancer diagnosis’ vari-
able, resulting in a final sample for analysis of n = 917. The
most commonly reported symptoms were persistent cough
or hoarseness (23%), persistent change in bowel habits
(18%), and persistent change in bladder habits (17%). The
least commonly reported symptoms were blood in urine
(5%), difficulty swallowing (5%), other unexplained bleeding
(3%) and breast changes (3%).
Most of the symptomatic patients (N = 859) reported
whether they had sought help for their symptom/s dur-
ing the last 3 months, with 63% (542/859) having visited
a GP. Spearman’s correlations revealed a large and sig-
nificant correlation between the two body vigilance
items (r = .55, p < .001). There were also small but sig-
nificant correlations between cancer worry and BV-
attention (r = 0.12, p < .01), and BV-sensitivity (r = 0.15,
p < .001).
Association between body vigilance and help-seeking
Logistic regression models are presented in Table 3. BV-
attention was associated with a significantly higher likeli-
hood of seeking help for at least one cancer alarm
symptom in multivariable analyses (OR = 1.44, 1.06-1.97).
BV-sensitivity was not associated with help-seeking in
multivariable analyses (OR = 1.02, 0.75-1.40).
In both regression models, unemployed/retired people
were significantly more likely to have sought help for at
Table 2 Demographic characteristics among symptomatic and
asymptomatic respondents
Symptomatic
(N = 917)
n (%)
Asymptomatic
(N = 1106)
n (%)
Sex Male 374 (40.8) 551 (49.8)
Female 534 (58.2) 543 (49.1)
Age 50–59 318 (34.7) 348 (31.5)
60–79 492 (53.7) 653 (59.0)
80+ 77 (8.4) 74 (6.7)
Marital Status Single/Not co-habiting 336 (36.6) 307 (27.8)
Married/Co-habiting 573 (62.5) 786 (71.1)
Education Below degree level 554 (60.4) 697 (63.0)
Degree or higher 341 (37.2) 389 (35.2)
Employment Not working 538 (58.7) 640 (57.9)
Working 368 (40.1) 451 (40.8)
Ethnicity Non-white 53 (5.8) 54 (4.9)
White 858 (93.6) 1046 (94.6)
Cancer worry Low cancer worry 739 (80.6) 984 (93.4)
High cancer worry 108 (11.8) 70 (6.6)
Current illness No 465 (50.7) 756 (68.4)
Yes 422 (46.0) 319 (28.8)
BV-sensitivity No 470 (51.3) 622 (56.2)
Yes 425 (46.3) 455 (41.1)
BV-attention No 438 (47.8) 539 (48.7)
Yes 468 (51.0) 549 (49.6)
Column totals may vary due to missing data (ranging from <1% (n = 6 for
ethnicity to 3% (n = 30) for age and current illness). BV-sensitivity ‘I am very
sensitive to changes in my body’, BV-attention ‘I pay close attention to changes
in my body’
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least one symptom (p < .01) and reporting a current ill-
ness was also associated with being more likely to have
sought help (p < .001).
Discussion
This is the first large-scale survey to explore associations
between body vigilance and help-seeking for people report-
ing cancer ‘alarm’ symptoms. The key finding was that
people who paid more attention to their body were more
likely to have sought help from their doctor. Despite the as-
sociation between cancer worry and body vigilance, and the
high positive correlation between ‘paying attention’ and ‘be-
ing sensitive’ to bodily changes, only ‘paying attention’ was
positively associated with help-seeking. Being unemployed/
retired and/or reporting a current illness were also found to
be independently associated with increased likelihood of
help-seeking in multivariable analysis.
This is the first time the relationship between body vigi-
lance and help-seeking has been demonstrated in the can-
cer context, and supports theoretical models of symptom
appraisal emphasising the importance of attentional process
in help-seeking for cancer ‘alarm’ symptoms [14]. Although
work on the relationship between body vigilance and cancer
diagnosis is scarce, a recent prospective study in Norway
found health anxiety (defined as persistent preoccupation
with developing a serious medical condition) was associated
with increased likelihood of a cancer diagnosis in men, but
not women [27]. It was suggested that men with high levels
of health anxiety are more likely to detect a malignant
tumour than men with lower levels of anxiety, which
may aid early cancer detection. However the mechan-
ism by which anxiety led to higher incidence of can-
cer diagnosis remains unclear.
Caution was also noted because health anxiety may lead
to overdiagnosis and overtreatment [27]. It is thus import-
ant to distinguish between ‘paying attention’ (getting to
know your body and being aware of changes) and active
self-checking. For example, for breast cancer, women who
regularly check their breasts are almost twice as likely to
have a biopsy of a benign lump but are no less likely to
die from cancer, and therefore active self-checking is
often not recommended [28]. However, promoting body
Table 3 Multivariable logistic regression models for the association between each of the body vigilance items (BV-sensitivity and BV-
attention) and help-seeking, controlling for potential confounders
Sought help for one or more symptom
N (%) sought help Univariable association between
confounder and help-seeking (p value)
Model including
BV-sensitivity
Adjusted ORa (95% CI)
Model including
BV-attention
Adjusted ORa (95% CI)
Sex Male 214 (61.3) 0.40 – –
Female 322 (64.1)
Age 50–59 183 (60.0) 0.30 – –
60–79 304 (65.5)
80+ 40 (62.5)
Marital Status Single/Not co-habiting 196 (63.0) 0.90 – –
Married/Co-habiting 344 (63.5)
Education No higher education 334 (65.0) 0.11 1.00 1.00
Degree or higher 196 (59.6) 0.85 (0.62–1.16) 0.83 (0.61–1.14)
Employment Working 196 (55.7) 0.00 1.00 1.00
Not Working 342 (69.0) 1.53 (1.11–2.09) 1.55 (1.13–2.13)
Ethnicity Non-white 38 (73.1) 0.13 1.00 1.00
White 510 (62.5) 0.60 (0.31–1.18) 0.58 (0.29–1.14)
Cancer worry Low worry 429(61.5) 0.13 1.00 1.00
High worry 70 (69.3) 1.45 (0.89–2.35) 1.37 (0.84–2.23)
Current illness No 237 (54.4) 0.00 1.00 1.00
Yes 286 (72.4) 2.11 (1.53–2.90) 2.08 (1.51–2.86)
BV-sensitivity Not endorsed 229 (62.1) 1.00 –
Endorsed 261 (64.3) 1.02 (0.75–1.40)
BV-attention Not endorsed 231 (57.6) – 1.00
Endorsed 303 (67.6) 1.44 (1.06–1.97)
aAdjusted for education, employment, ethnicity, cancer worry and current illness. Highlighted figures are statistically significant (p < 0.05). OR odds ratio, CI
confidence interval, BV-sensitivity ‘I am very sensitive to changes in my body’, BV-attention ‘I pay close attention to changes in my body’
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vigilance in developing countries where, for example,
women present with late stage disease of breast cancer
may be beneficial [29, 30].
There was no significant association between cancer
worry and help-seeking, and body vigilance was inde-
pendently associated with help-seeking. One potential
explanation is the mixed role of emotion in help-seeking
[31], where cancer worry can act both as a barrier and
facilitator to contacting a health care professional [32].
In line with existing research, unemployed/retired people
were more likely to seek help for their symptoms [25]. This
may be explained by unemployed/retired people having less
competing stimuli for their attention and therefore more
cognitive resources available for noticing and responding to
internal bodily changes [33]. Respondents reporting current
illnesses were also more likely to have sought help for their
symptom, and this was the strongest predictor of help-
seeking in the current study in multivariable analysis. This
supports previous research where people described men-
tioning a worrying symptom when consulting about some-
thing else [34].
Limitations
Despite being broadly representative of over 50 year olds
in the UK [25], non-white ethnic groups were under-
represented in this study, and targeted work on body vigi-
lance in different communities may be beneficial. Our re-
sponse rate was 42%, which is higher than other primary
care based surveys [35]. However, the finding that men
and younger people were less likely to respond limits the
generalisability of these findings.
As recognised previously [20], the bias associated with
questionnaire return cannot be estimated - experience of
symptoms could both encourage and discourage it. For
example, people who do not respond to surveys may be
more avoidant generally, and less likely to attend to bodily
changes or seek help. The prevalence of hypochondriasis in
the current population is also unknown, and as this is asso-
ciated with elevated body vigilance [18], may also influence
questionnaire return. However, in population-based studies
prevalence rates of hypochondriasis are estimated to range
between 0.2 and 4.5% [36] so this is unlikely to have had a
significant impact on the findings of the present study.
It should also be noted that the use of a cross-sectional
study design limits any inferences concerning the direc-
tions of the observed associations. For example, certain
forms of help-seeking may be conducive to greater body
vigilance or associations may exist in both directions.
Our findings are based on self-reported body vigilance
using items developed outside the cancer field, and single
items were used to assess cancer worry, help seeking, and
each component of body vigilance, which could raise ques-
tions about their reliability and validity. It might be interest-
ing to qualify what people mean when reporting ‘attention’
to bodily changes to clarify conceptual differences between
sensitivity to bodily changes compared to being atten-
tive. This information could advance our understanding
in terms of whether and how people distinguish between
these two types of body vigilance. A number of cancer
‘alarm’ symptoms were pooled in the present analyses but
future research could explore the influence of body vigi-
lance at the symptom level.
There could be some concern over whether encouraging
body vigilance might lead people to become overly anxious
about bodily changes, particularly in light of established as-
sociations between anxiety and body vigilance [18] . Simi-
larly, some may worry that encouraging people attend to
unusual changes may direct a large number of people to
primary care, possibly overloading the healthcare system
with the ‘worried well’ [37]. In most cases, ‘alarm’ symptoms
will not be indicative of cancer [38], and body vigilance in-
terventions should be designed so they do not provoke
undue anxiety or encourage unnecessary help-seeking. To
further understand the implications of these findings, future
longitudinal studies could explore the impact of body vigi-
lance on help-seeking behaviour.
Conclusion
People who paid attention to bodily changes were more
likely to seek help for cancer ‘alarm’ symptoms. Efforts to
encourage body vigilance without causing excessive anx-
iety could be useful when designing early detection inter-
ventions. In turn, this could result in timelier help-seeking
and may contribute towards earlier cancer diagnosis.
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